Teng Fei, Fussenegger Martin
Department of Biosystems Science and Engineering ETH Zurich Mattenstrasse 26 Basel CH-4058 Switzerland.
Faculty of Science University of Basel Mattenstrasse 26 Basel CH-4058 Switzerland.
Adv Sci (Weinh). 2020 Nov 27;8(1):2003505. doi: 10.1002/advs.202003505. eCollection 2020 Jan.
Extracellular vesicles (EVs) are biocompatible, nano-sized secreted vesicles containing many types of biomolecules, including proteins, RNAs, DNAs, lipids, and metabolites. Their low immunogenicity and ability to functionally modify recipient cells by transferring diverse bioactive constituents make them an excellent candidate for a next-generation drug delivery system. Here, the recent advances in EV biology and emerging strategies of EV bioengineering are summarized, and the prospects for clinical translation of bioengineered EVs and the challenges to be overcome are discussed.
细胞外囊泡(EVs)具有生物相容性,是纳米级的分泌囊泡,包含多种生物分子,包括蛋白质、RNA、DNA、脂质和代谢物。它们的低免疫原性以及通过传递多种生物活性成分在功能上修饰受体细胞的能力,使其成为下一代药物递送系统的理想候选者。本文总结了EV生物学的最新进展以及EV生物工程的新兴策略,并讨论了生物工程EV临床转化的前景和需要克服的挑战。